Kuo, H., Hsu, Y., Wu, M., Woon, P. Y., Wong, H. S., Tsai, L., . . . Chang, W. FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease. Wiley.
Chicago Style (17th ed.) CitationKuo, Ho-Chang, et al. FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease. Wiley.
MLA (9th ed.) CitationKuo, Ho-Chang, et al. FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease. Wiley.
Warning: These citations may not always be 100% accurate.